chr16-78115155-G-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_016373.4(WWOX):c.409+1G>C variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_016373.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WWOX | NM_016373.4 | c.409+1G>C | splice_donor_variant, intron_variant | ENST00000566780.6 | NP_057457.1 | |||
WWOX | NM_001291997.2 | c.70+1G>C | splice_donor_variant, intron_variant | NP_001278926.1 | ||||
WWOX | NM_130791.5 | c.409+1G>C | splice_donor_variant, intron_variant | NP_570607.1 | ||||
WWOX | NR_120436.3 | n.648+1G>C | splice_donor_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WWOX | ENST00000566780.6 | c.409+1G>C | splice_donor_variant, intron_variant | 1 | NM_016373.4 | ENSP00000457230.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249086Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135228
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461862Hom.: 0 Cov.: 34 AF XY: 0.00000825 AC XY: 6AN XY: 727234
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autosomal recessive spinocerebellar ataxia 12;C3463992:Developmental and epileptic encephalopathy, 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2021 | Disruption of this splice site has been observed in individuals with WWOX- related conditions (PMID: 27848944, 30746283). This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 4 of the WWOX gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in WWOX are known to be pathogenic (PMID: 24456803, 25411445). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Developmental and epileptic encephalopathy, 28 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Nov 03, 2021 | The WWOX c.409+1G>C variant occurs in a canonical splice site (donor) and is therefore predicted to disrupt the normal gene product. The c.409+1G>C variant has not been reported before, but c.409+1G>T has been reported in a homozygous state in a proband affected with seizures, global developmental delay, microcephaly, subtle dysmorphic features, kyphosis with short clavicles, scoliosis, occasional horizontal nystagmus, spasticity in both upper and lower limbs with decreased deep tendon reflexes, axial hypotonia, brain atrophy and increased white matter signal in cerebellar area (Ehaideb et al. 2018). The c.409+1G>C variant is present at a frequency of 0.000009 in the European (Non-Finnish) population of the Genome Aggregation Database version 2.1.1, though this is based on one allele in a region of good sequence coverage so the variant is presumed to be rare. Based on the available evidence, the c.409+1G>C variant is classified as likely pathogenic for WWOX-related developmental and epileptic encephalopathy. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at